Cargando…
Understanding and targeting resistance mechanisms in cancer
Resistance to cancer therapies has been a commonly observed phenomenon in clinical practice, which is one of the major causes of treatment failure and poor patient survival. The reduced responsiveness of cancer cells is a multifaceted phenomenon that can arise from genetic, epigenetic, and microenvi...
Autores principales: | Lei, Zi‐Ning, Tian, Qin, Teng, Qiu‐Xu, Wurpel, John N. D., Zeng, Leli, Pan, Yihang, Chen, Zhe‐Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203373/ https://www.ncbi.nlm.nih.gov/pubmed/37229486 http://dx.doi.org/10.1002/mco2.265 |
Ejemplares similares
-
Signaling pathways and therapeutic interventions in gastric cancer
por: Lei, Zi-Ning, et al.
Publicado: (2022) -
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
por: Wang, Jing-Quan, et al.
Publicado: (2020) -
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells
por: Lei, Zi‐Ning, et al.
Publicado: (2021) -
The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide
por: Teng, Qiu-Xu, et al.
Publicado: (2020) -
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor
por: Wu, Zhuo-Xun, et al.
Publicado: (2021)